Charles B. Spainhour

571 total citations
23 papers, 397 citations indexed

About

Charles B. Spainhour is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Charles B. Spainhour has authored 23 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Genetics. Recurrent topics in Charles B. Spainhour's work include Erythropoietin and Anemia Treatment (4 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Charles B. Spainhour is often cited by papers focused on Erythropoietin and Anemia Treatment (4 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Charles B. Spainhour collaborates with scholars based in United States, United Kingdom and New Zealand. Charles B. Spainhour's co-authors include Shayne C. Gad, Dexter W. Sullivan, James D. Crapo, Arthur A. Levin, Richard S. Geary, Janet M. Leeds, Moire R. Creek, Todd Burckin, L Truong and Kathryn W. Woodburn and has published in prestigious journals such as Blood, Biochemical Pharmacology and Tetrahedron Letters.

In The Last Decade

Charles B. Spainhour

23 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles B. Spainhour United States 13 155 56 41 39 36 23 397
Siobhan E. Moriarty-Craige United States 7 327 2.1× 20 0.4× 46 1.1× 17 0.4× 26 0.7× 7 618
Marilyn S. Arnott United States 8 183 1.2× 34 0.6× 28 0.7× 14 0.4× 40 1.1× 9 424
Jason E. Drury United States 13 371 2.4× 17 0.3× 39 1.0× 64 1.6× 18 0.5× 15 755
Mengrong Li China 11 238 1.5× 63 1.1× 31 0.8× 13 0.3× 10 0.3× 36 482
Paul D. Colman United States 12 414 2.7× 26 0.5× 18 0.4× 47 1.2× 15 0.4× 21 625
Francis Fouchier France 13 202 1.3× 12 0.2× 47 1.1× 18 0.5× 54 1.5× 25 434
Manik Ganguly United States 12 150 1.0× 19 0.3× 54 1.3× 20 0.5× 24 0.7× 16 456
Lydia Seyfarth Germany 11 199 1.3× 12 0.2× 24 0.6× 46 1.2× 58 1.6× 30 391
Kathryn M. Brown United States 10 131 0.8× 16 0.3× 63 1.5× 60 1.5× 8 0.2× 22 355
Wei-De Lin Taiwan 12 217 1.4× 16 0.3× 16 0.4× 35 0.9× 15 0.4× 25 434

Countries citing papers authored by Charles B. Spainhour

Since Specialization
Citations

This map shows the geographic impact of Charles B. Spainhour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles B. Spainhour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles B. Spainhour more than expected).

Fields of papers citing papers by Charles B. Spainhour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles B. Spainhour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles B. Spainhour. The network helps show where Charles B. Spainhour may publish in the future.

Co-authorship network of co-authors of Charles B. Spainhour

This figure shows the co-authorship network connecting the top 25 collaborators of Charles B. Spainhour. A scholar is included among the top collaborators of Charles B. Spainhour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles B. Spainhour. Charles B. Spainhour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gad, Shayne C., et al.. (2019). Nonclinical Safety and Toxicokinetics of MnTE-2-PyP (BMX-010), a Topical Agent in Phase 2 Trials for Psoriasis and Atopic Dermatitis. International Journal of Toxicology. 38(4). 291–302. 5 indexed citations
3.
Gad, Shayne C. & Charles B. Spainhour. (2017). Nonclinical Drug Administration. 1 indexed citations
4.
Gad, Shayne C., et al.. (2016). Tolerable Levels of Nonclinical Vehicles and Formulations Used in Studies by Multiple Routes in Multiple Species With Notes on Methods to Improve Utility. International Journal of Toxicology. 35(2). 95–178. 54 indexed citations
5.
Gad, Shayne C., et al.. (2016). Nonclinical Safety and Toxicokinetics of MnTnBuOE-2-PyP5+(BMX-001). International Journal of Toxicology. 35(4). 438–453. 25 indexed citations
6.
Gad, Shayne C., Dexter W. Sullivan, James D. Crapo, & Charles B. Spainhour. (2013). A Nonclinical Safety Assessment of MnTE-2-PyP, a Manganese Porphyrin. International Journal of Toxicology. 32(4). 274–287. 28 indexed citations
7.
Gad, Shayne C. & Charles B. Spainhour. (2011). Contract Research and Development Organizations. DIAL (Catholic University of Leuven). 1 indexed citations
8.
Woodburn, Kathryn W., et al.. (2008). Chronic preclinical safety evaluation of HematideTM, a pegylated peptidic erythropoiesis stimulating agent in monkeys. Haematologica. 93(9). 1376–1379. 18 indexed citations
9.
Woodburn, Kathryn W., Susan Wilson, K L Fong, et al.. (2008). Chronic Pharmacological and Safety Evaluation of Hematide™, a PEGylated Peptidic Erythropoiesis‐Stimulating Agent, in Rodents. Basic & Clinical Pharmacology & Toxicology. 104(2). 155–163. 17 indexed citations
10.
Woodburn, Kathryn W., Peter J. Schatz, K L Fong, et al.. (2008). Preclinical Safety and Pharmacology of Hematide™, a Peptidic Erythropoiesis Stimulating Agent (ESA), in Rats and Monkeys. Drug and Chemical Toxicology. 31(2). 229–244. 19 indexed citations
11.
Serfilippi, Laurie, et al.. (2004). Assessment of retinal degeneration in outbred albino mice.. PubMed. 54(1). 69–76. 22 indexed citations
12.
Geary, Richard S., Janet M. Leeds, Todd Burckin, et al.. (1997). Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.. PubMed. 25(11). 1272–81. 88 indexed citations
13.
Mayura, Kittane, et al.. (1993). Teratogenicity and immunotoxicity of 3,3′,4,4′,5-pentachlorobiphenyl in C57BL/6 mice. Toxicology. 77(1-2). 123–131. 21 indexed citations
14.
Mayura, Kittane, et al.. (1993). Evaluation of the developmental toxicity of citrinin using Hydra attenuata and postimplantation rat whole embryo culture. Toxicology. 85(2-3). 179–198. 12 indexed citations
15.
Bratton, Gerald R., et al.. (1993). Presence and potential effects of contaminants. 2. 701–744. 9 indexed citations
16.
Flory, Wayne, et al.. (1992). The Toxicologic Investigation of a Feed Grain Contaminated with Seeds of the Plant SpeciesCassia. Journal of Veterinary Diagnostic Investigation. 4(1). 65–69. 13 indexed citations
17.
Spainhour, Charles B., Robert A. Fiske, Wayne Flory, & John C. Reagor. (1990). A Toxicological Investigation of the Garden Shrub Brunfelsia Calcyina var. Floribunda (Yesterday-Today-and-Tomorrow) in Three Species. Journal of Veterinary Diagnostic Investigation. 2(1). 3–8. 7 indexed citations
18.
Mendelson, Wilford L., et al.. (1984). Two syntheses of 7,8‐dichloro‐1,2,3,4‐tetrahydroisoquinoline‐1‐14C. Journal of Labelled Compounds and Radiopharmaceuticals. 21(10). 961–972. 1 indexed citations
19.
Mendelson, Wilford L., et al.. (1980). Intramolecular friedel-crafts alkylations. II. An efficient synthesis of biologically active 1,2,3,4-tetrahydroisoquinolines. Tetrahedron Letters. 21(15). 1393–1396. 21 indexed citations
20.
Newman, David, et al.. (1978). cAMP-phosphodiesterase inhibitors and tracheal smooth muscle relaxation. Biochemical Pharmacology. 27(5). 729–732. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siobhan E. Moriarty-Craige Breakdown of academic impact, for papers by Marilyn S. Arnott Breakdown of academic impact, for papers by Jason E. Drury Breakdown of academic impact, for papers by Mengrong Li Breakdown of academic impact, for papers by Paul D. Colman Breakdown of academic impact, for papers by Francis Fouchier Breakdown of academic impact, for papers by Manik Ganguly Breakdown of academic impact, for papers by Lydia Seyfarth Breakdown of academic impact, for papers by Kathryn M. Brown Breakdown of academic impact, for papers by Wei-De Lin
Rankless by CCL
2026